InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,187.70
(
0.13%
)
US TECH 100
17,618.80
(
0.05%
)
Dow Jones
38,884.26
(
0.08%
)
Brent Oil
82.58
(
-0.35%
)
Bitcoin
62,596.44
(
0.42%
)
Post# of 6280
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Prudent Capitalist

Send PM Follow Ignore
Followers 134
Posts 17942
Boards Moderated 9
Alias Born 05/28/2009

Prudent Capitalist

Re: drpat post# 5909

Friday, 03/28/2014 12:42:59 PM

Friday, March 28, 2014 12:42:59 PM

Post# of 6280
I agree all the news is great, and we just had that great surge up to $5.00 on very high volume. Hard to figure, but still several reputable firms with price3 targets in the $7 - $15 range on AVNR. One thing that would help is a positive ruling on the last 2 patent cases. The major pharma's all settled and agreed to hold off on the generic for Nuedexta until August of 2026. That decision would appear to bode well for AVNR with the 2 smaller more obscure pharma's that5 went to trial on the issue. Decision should come any day now.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up